Published in Drug Week, June 24th, 2011
"Here, we used the sigma R1-knockout mouse (Sigmar1(-/-)) to demonstrate unambiguously the role of the sigma R1 in protecting the retinal ganglion cells against degeneration after acute damage to the optic nerve. Retinal sigma R binding sites were labeled with radioiodinated sigma R ligands and...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.